InvestSMART

SomnoMed Limited (ASX: SOM) - Announcements

- Current share price for SOM : $0.490

ASX company news and announcements for SomnoMed Limited (SOM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SomnoMed Limited (SOM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SomnoMed Limited (SOM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SomnoMed Limited (SOM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$107 Acquisition of Dutch Oral Appliance Distribution Company 17 Jan 2012 9:43AM $0.970 $0.490 fallen by 49.48%
$107 Appendix 4C - quarterly 26 Oct 2011 2:24PM $1.100 $0.490 fallen by 55.45%
$107 US Medicare PDAC registration approved 26 Sep 2011 10:19AM $1.120 $0.490 fallen by 56.25%
$107 Investor presentation 29 Aug 2011 9:37AM $1.200 $0.490 fallen by 59.17%
$107 Preliminary Final Report 25 Aug 2011 2:55PM $1.120 $0.490 fallen by 56.25%
$107 Appendix 4C - quarterly 27 Jul 2011 2:03PM $1.400 $0.490 fallen by 65%
$107 Appendix 4C - quarterly 29 Apr 2011 1:01PM $1.345 $0.490 fallen by 63.57%
$107 SomnoMed posts new record in Q3 29 Apr 2011 1:01PM $1.300 $0.490 fallen by 62.31%
$107 Half Yearly Report and Accounts 24 Feb 2011 2:54PM $1.300 $0.490 fallen by 62.31%
$107 CEO transfers to US 7 Feb 2011 12:47PM $0.930 $0.490 fallen by 47.31%
$107 Quarterly Cashflow Report 27 Jan 2011 1:48PM $0.930 $0.490 fallen by 47.31%
$107 SomnoMed reports solid growth and stronger profits 28 Oct 2010 12:24PM $1.040 $0.490 fallen by 52.88%
$107 Appendix 4C - quarterly 28 Oct 2010 12:22PM $1.050 $0.490 fallen by 53.33%
$107 SomnoMed Announces Sleep Apnea Management Program 20 Oct 2010 10:35AM $1.000 $0.490 fallen by 51%
$107 Preliminary Final Report 26 Aug 2010 11:10AM $0.880 $0.490 fallen by 44.32%
$107 Appendix 4C - quarterly 26 Jul 2010 11:30AM $0.810 $0.490 fallen by 39.51%
$107 SomnoMed finishes year with record quarter 26 Jul 2010 11:30AM $0.800 $0.490 fallen by 38.75%
$107 Somnomed expands business and operations in Europe 2 Jul 2010 10:26AM $0.795 $0.490 fallen by 38.36%
$107 Somnomed introduces new Medical product 29 Jun 2010 10:36AM $0.795 $0.490 fallen by 38.36%
$107 Appendix 4C - quarterly 29 Apr 2010 10:02AM $0.960 $0.490 fallen by 48.96%
$107 Half Yearly Report and Accounts 18 Feb 2010 11:12AM $0.950 $0.490 fallen by 48.42%
$107 Quarterly Cashflow Report 27 Jan 2010 9:56AM $0.855 $0.490 fallen by 42.69%
$107 SomnoMed Accelerates Growth beyond Forecasts 27 Jan 2010 9:49AM $0.850 $0.490 fallen by 42.35%
$107 Launch of new product line to treat Sleep Bruxism 19 Jan 2010 9:22AM $0.830 $0.490 fallen by 40.96%
$107 Somnomed enters strategic partnerships in the USA 9 Nov 2009 10:24AM $0.052 $0.490 risen by 842.31%

601 - 625 of 675 results

Page 25 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.